India's Health Minister calls for a robust drug regulation framework to maintain "pharmacy of the world" status, citing recent US FDA and EMA contamination reports.
India needs a robust drug regulation framework to maintain its 'pharmacy of the world' tag, said Union Health Minister JP Nadda. At a high-level review meeting on drug, cosmetics, and medical device regulation, Nadda emphasized the need for a world-class regulatory framework to match the scale of operations and international expectations. Recent contaminations in India-made drugs by US FDA and European Medicines Agency highlight the importance of such a framework.
July 17, 2024
10 Articles